World's Best Scientists 2026 revealed!
Christoph Lange

Christoph Lange

D-Index & Metrics

Medicine

D-Index
121
Citations
49351
World Ranking
3631
National Ranking
195

Overview

Christoph Lange is affiliated with the University of Lübeck in Germany and has contributed extensively to research in the field of medicine, with a particular focus on infectious diseases and tuberculosis. They have a strong emphasis on interdisciplinary approaches that span epidemiology, pulmonary and respiratory medicine, and immunology.

The scientist's research covers a variety of topics related to infectious diseases, including tuberculosis research and epidemiology, Mycobacterium research and diagnosis, and pneumonia and respiratory infections. Other notable areas of work include Pneumocystis jirovecii pneumonia detection and treatment, as well as infectious diseases combined with mycology.

Some recent publications by Christoph Lange include:

  • Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline, 2020, European Respiratory Journal
  • Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline, 2020, Clinical Infectious Diseases
  • Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline, 2020, Clinical Infectious Diseases
  • Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19, 2020, Immunity
  • The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis, 2020, The Lancet

Frequent co-authors in their work include Jan Heyckendorf, Anna M. Mandalakas, Maja Reimann, Dumitru Chesov, and Andrew R. DiNardo.

Christoph Lange publishes regularly in several notable journals, with the highest number of contributions appearing in:

  • European Respiratory Journal
  • Clinical Microbiology and Infection
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The International Journal of Tuberculosis and Lung Disease
  • Pneumologie

Their main field of study is medicine, encompassing over 460 publications, with significant specialization in infectious diseases and epidemiology, which account for more than 300 combined publications. Pulmonary and respiratory medicine along with immunology represent additional subfields of their expertise.

Best Publications

  • Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline

    Charles L. Daley;Jonathan M. Iaccarino;Christoph Lange;Emmanuelle Cambau

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning

  • Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management

    David W. Denning;Jacques Cadranel;Catherine Beigelman-Aubry;Florence Ader

  • A common genetic variant is associated with adult and childhood obesity.

    Alan Herbert;Norman P. Gerry;Matthew B. McQueen;Iris M. Heid

  • Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary

    Charles L Daley;Jonathan M Iaccarino;Christoph Lange;Emmanuelle Cambau

  • Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis

    R. Diel;D. Goletti;G. Ferrara;G. Bothamley

  • Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis

    Martina Sester;Giovanni Sotgiu;Christoph Lange;Claudia Giehl

  • The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

    Keertan Dheda;Tawanda Gumbo;Gary Maartens;Kelly E. Dooley

  • The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

    I. Solovic;M. Sester;J. J. Gomez-Reino;H. L. Rieder

  • Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

    Nafees Ahmad;Shama D Ahuja;Onno W Akkerman

  • Family-based designs in the age of large-scale gene-association studies.

    Nan M. Laird;Christoph Lange

  • Genome-wide association scan of quantitative traits for Attention Deficit Hyperactivity Disorder identifies novel associations and confirms candidate gene associations

    Jessica Lasky-Su;Benjamin M. Neale;Barbara Franke;Richard J.L. Anney

  • Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE

    Lars Bertram;Christoph Lange;Kristina Mullin;Michele Parkinson

  • MMP12, lung function, and COPD in high-risk populations.

    Gary M. Hunninghake;Michael H. Cho;Yohannes Tesfaigzi;Manuel E. Soto-Quiros

  • Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

    Dennis Falzon;Neel Gandhi;Giovanni B. Migliori;Giovanni Sotgiu

  • Variants in FAM13A are associated with chronic obstructive pulmonary disease

    Michael H. Cho;Nadia Boutaoui;Barbara J. Klanderman;Jody S. Sylvia

  • Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma

    Kelan Tantisira;Jessica A. Lasky Lasky-Su;Michishige Harada;Amy Murphy

  • The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation.

    Antje Blumenthal;Stefan Ehlers;Jörg Lauber;Jan Buer

  • Treatment of Tuberculosis.

    C. Robert Horsburgh;Clifton E. Barry;Christoph Lange

  • Extensively drug-resistant tuberculosis, Italy and Germany.

    Giovanni Battista Migliori;Johannes Ortmann;Enrico Girardi;Giorgio Besozzi

Frequent Co-Authors

Scott T. Weiss
Scott T. Weiss Harvard University
Edwin K. Silverman
Edwin K. Silverman Brigham and Women's Hospital
Benjamin A. Raby
Benjamin A. Raby Brigham and Women's Hospital
Jessica Lasky-Su
Jessica Lasky-Su Brigham and Women's Hospital
Giovanni Sotgiu
Giovanni Sotgiu University of Sassari
Dawn L. DeMeo
Dawn L. DeMeo Brigham and Women's Hospital
Michael H. Cho
Michael H. Cho Harvard University
Giovanni Battista Migliori
Giovanni Battista Migliori Queen Mary University of London
Lars Bertram
Lars Bertram University of Lübeck
Ross Lazarus
Ross Lazarus Baker IDI Heart and Diabetes Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in Medicine but want to explore other healthcare careers or entry points, there are several accessible online pathways to choose from. For those interested in nursing with fewer barriers to acceptance, adn programs are a popular option, offering a quicker route to registered nursing roles compared to traditional degrees.

Another rewarding option is medical billing and coding. Many students are attracted by the flexible, remote learning opportunities and the availability of financial aid for medical billing and coding online classes, making this pathway more affordable and accessible.

For those considering practical nursing, you might wonder: do i need to take the teas test for lpn? Some accredited programs allow students to skip entrance exams like TEAS or HESI, making entry even easier.

If your interests lie in healthcare management, pursuing healthcare administration degrees can lead to impactful leadership roles, often completed in an accelerated online format. Each of these pathways can help you advance in the healthcare sector, tailored to your goals and lifestyle.

Best Scientists Citing Christoph Lange

Trending Scientists